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Conclusion: A method has been developed to assist the 
adaptive planning process for lung patients receiving FFF 
VMAT radiotherapy. This provides a means of assessing the 
dosimetric effect of tumour changes to determine whether a 
new treatment plan is necessary. It showed that for 25% of 
patients who received full treatment replans no replan was 
necessary, as the dosimetric effect of tumour shrinkage was 
insignificant in terms of both target coverage and OAR doses. 
Therefore it allows significant time savings in the treatment 
replanning process. Use of the technique is limited to 
patients who display tumour volume changes with no other 
significant changes to internal/external anatomy. 
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Purpose or Objective: The Gamma Knife Icon (Elekta AB, 
Schweden) allows frameless treatment of patients in a 
precise stereotactic environment using a combination of 
cone-beam computer tomography (CBCT) for positioning, a 
thermoplastic mask system for positioning and fixation and an 
infrared based camera system “high definition motion 
management” (HDMM) for patient tracking during treatment. 
Using these novel options, the Gamma Knife Icon provides the 
possibility for adaptive fractionated stereotactic 
radiotherapy (a-gkFSRT). Here we report the treatment of 
the first patient with a-gkFSRT. 
 
Material and Methods: The first patient treated with Gamma 
Knife Icon at the University Medical Center Mannheim 
received MR imaging with an individual cushion for pre-
planning with the treatment planning system (TPS) 
GammaPlan 11.0.1 (Elekta AB, Schweden) 7 days before 
treatment. For every fraction of the treatment a daily CBCT 
was performed to verify the actual scull/tumour position. An 
automatic co-registration was performed to determine the 
daily shift in translation and rotation. The TPS adapted 
automatically the shot positions to the daily position and 
recalculated the dose distribution (online adaptive planning). 
During the treatment the HDMM system recorded the intra-
fractional patient motion. Further we recorded the times for 
positioning, image guidance and treatment to define a 
clinical treatment slot. 
 
Results: The total treatment time for fraction 2-5 was around 
20 minutes. The positioning of the patient needed 0.8 min, 
CBCT positioning plus acquisition 1.03 min plus 0.62 min, CT 
data processing and adaptive planning 2.66 min and 
treatment 15.6 minutes. The mean values and standard 
deviations for the 5 daily CBCTs compared to the reference 
scan are for rotation -0.59°±0.49/0.18±0.20/0.05°±0.36 and 
for translation are 0.94mm±0.52/-0.08mm±0.08/-
1.13mm±0.89. The adaptive re-planning (duration 1.25 
minutes) every day was very accurate and yielded quality 
measures e.g. coverage, selectivity and gradient for the 
delivered dose identical regarding to the initial values. Using 
the HDMM system over all fractions we saw an intra-fractional 
movement of 0.13±0.04mm. The intra-fractional movement 
was controlled by the HDMM system and showed similar 
results as a repeated CBCT after treatment (<0.32° and 
0.20mm). 
 
Conclusion: The Gamma Knife Icon allows combining the 
accuracy of the stereotactic Gamma Knife system with the 
flexibility of fractionated treatment of a linear accelerator 
with mask system and CBCT. Further the Icon system 
introduces a new online patient tracking system to the 
clinical routine. The inter-fractional accuracy of patient 
positioning was controlled with a thermoplastic mask and 
CBCT. The adaptive re-planning was quick and yielded high 
quality plans. Identical dose was delivered each day because 
of adaptive re-planning. 
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Purpose or Objective: The aim of this study was to report 
the results of the validation of a previously developed 
method for dose of the day calculation in head and neck 
Tomotherapy based on deformable image registration (DIR) of 
the planning CT to MVCT taken during treatment.  
 
Material and Methods: kVCT/MVCT images of ten HN patients 
treated with Helical Tomotherapy (HT) with a simultaneous 
integrated boost (54/66/69 Gy/30 fr) were retrospectively 
analyzed. For each patient the planning kVCT (CT-plan) was 
elastically registered (DIR) to the MVCT acquired at the 15th 
therapy session (MVCT15) with a B-Spline deformation 
algorithm using Mattes mutual information (open-source 
software 3D Slicer), resulting in a deformed CT (CTdef). At 
the same day, a kVCT was acquired with the patient in the 
same treatment position (CT15) and taken as reference. 
Then, CTdef and CT15 were re-sampled to the same slice 
thickness (3mm) through linear interpolation. The original HT 
plans were recalculated both on CTdef and CT15 in the HT 
planning station using the DQA (dose quality assurance) 
module, considering the two set of images as phantoms: 
images were rigidly aligned with the CT-plan, mimicking the 
true daily repositioning. Dose distributions on CTdef and 
CT15 were compared in order to assess the reliability of the 
method; local dose differences <2% of the prescribed dose 
(DD2%) and global gamma-index values (2%-2mm; considering 
points with dose >20% of the prescribed one) were assessed 
for all the available transversal slices (step: 6 mm) with 
Mapcheck SNC Patient Software (Sun Nuclear).  
 
Results: The results of DIR was qualitatively satisfactory 
when comparing CTdef against CT15. On average, 94.4% ± 
0.9% of points passes the gamma analysis test and 87.9% ± 
1.1% of the body‘s voxel were found for DD2% (on average 27 
slices available for each patient). If excluding 3 patients 
where a relevant number of slices were cut due to the 
narrow FOV of the MVCT15, the values further improved to 
95.7% ± 0.8% and 89.1% ± 1.3% for gamma and DD2% 
respectively.  
 
 
Conclusion: CT to MVCT DIR using an open source system was 
proven to be an accurate method for calculating the dose of 
